发明名称 |
LABELED PE2I FORMULATION AND METHOD |
摘要 |
A diagnostic formulation is provided comprising a tropane having a radioactive concentration of at least 1.6 mCi/mL at least about 51 hours post creation. The diagnostic formulation optionally comprises a radiolabeled dopamine transporter (DAT) ligand useful in the diagnosis of Parkinson's disease (PS). One example of a radiolabeled dopamine transporter (DAT) ligand example is [123I]-N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β-(4-methylphenyl) nortropane. |
申请公布号 |
US2014079634(A1) |
申请公布日期 |
2014.03.20 |
申请号 |
US201314026366 |
申请日期 |
2013.09.13 |
申请人 |
NAVIDEA BIOPHARMACEUTICALS INC. |
发明人 |
HABER STEPHEN B.;THORN RICHARD |
分类号 |
A61K51/04;C07D451/02 |
主分类号 |
A61K51/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|